Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New plasmonic sensor improves early cancer detection

31.05.2017

A new plasmonic sensor developed by researchers at the University of Illinois at Urbana-Champaign will serve as a reliable early detection of biomarkers for many forms of cancer and eventually other diseases.

The sensor has been proven reliable to detect the presence of the cancer biomarker carcinoembryonic antigen (CEA) to the magnitude of 1 nanogram per milliliter. Most humans carry at least some amounts of CEA with an average range of 3-5 nanograms per milliliter. The researchers chose to focus on CEA because its presence in higher concentrations is an early indicator of many forms of cancer, including lung and prostate cancers.


This image shows a plasmonic nanocup metal-insulator-metal cavity design used to detect the cancer biomarker CEA. The nanocavity leads to optical energy storage which is out-coupled to the far field by a refractive index increase. Therefore, CEA binding to its immobilized antibody leads to a sensitive increase in the transmission intensity at the resonance wavelength with no spectral shift.

Credit: University of Illinois

"Cancer is one of the major causes of death in the United States as more than half of the new patients are diagnosed after it has already spread," Ameen explained. "This shows the gravity with which this problem needs to be addressed and this new design of a plasmonic sensor helps to detect the lower concentration of CEA at an earlier state."

The plasmonic sensor is an improvement of the current state-of-the-art method for a few reasons. First, it was able to improve the limit of detection by at least two orders of magnitude. In fact, most methods aren't able to accurately detect the presence of CEA until it reaches a higher concentration.

Secondly, because it works with much less instrumentation, it is less expensive and more portable and doesn't require nearly the expertise to make a reading. It also means instead of needing a vile of blood for a test, a simple finger prick will do. This aspect will be especially important for those who don't live close to an advanced medical facility, including those in developing nations.

The research team was led by Logan Liu, and Lynford Goddard, associate professors of electrical and computer engineering with students Abid Ameen and Lisa Hackett carrying out the project. The team published its results in Advanced Optical Materials as a cover article.

The device combines two sensing methods, which hadn't until this time been able to be used together. First, it uses a 3D multi-layer nanocavity in a nanocup array, which allows for the light to be stored in the cavity comprised of two metal layers (in this case gold) surrounding one insulator layer.

Secondly, it uses plasmonic sensing, which detects sensitive nanoscale light-matter interactions with biomolecules on the device surface. It produces an enhanced field confinement and an enhanced localized field. Because of the plasmonic structure, the light is out-coupled more efficiently as the surrounding refractive index changes.

"By combining plasmonic properties and the optical cavity properties together in one device we are able to detect lower concentration of biomarker by light confinement and transmission in the cavity layer and from the top of the device respectively, based on the thickness of the multilayers and the refractive index of the cavity layer," Ameen explained.

"The nanocup array provides extraordinary optical transmission," Hackett added. "If you take a thin metal film and try to shine light through it, there will be almost no light transmitted. However if you put a periodic array of nanoholes, or in our case a nanocup structure, then what you see is a resonance condition where at a certain wavelength, you will have a peak in the transmission through this device."

Because the resonance is changing at a single wavelength and because the spectral features have reference locations, excitation and detection can be done reliably without any specialized equipment. With this device, a LED light source can be used instead of a laser and a photocell or camera image can be used instead of a high-end spectrometer.

"Because of our multi-layer high-performing plasmonic structure, we were able to very efficiently scatter out the light to the far field," Hackett said. "When you increase the refractive index of the sensing region, it causes the stored energy to couple out. Usually when you have these types of refractometric plasmonic sensors, you have a shift in the angle or a change in your wavelength when the resonance condition is met. In our case, because we have incorporated a nanocavity, we have a fixed resonance wavelength."

As the concentration of biomolecules (in this case CEA) increases, so does the refractive index, which produces an increase of the transmission intensity at a fixed wavelength that can be easily detected.

"What that means in the future is we can take this sensor, which we've optimized and incorporated with an LED and have the most compact instrumentation, in fact no sophisticated instrumentation at all," Ameen said. "This allows high performance plasmonic sensing the ability to go toward portable sensing systems and large scale portable sensors."

For now, detection methods for cancer biomarkers are being implemented in high-risk patients, especially cancer patients in remission. They take time, specialized equipment, and are labor-intensive.

In the future, however, because of the portability and inexpensive nature of this method, it can be more easily administered to any patient at routine check-ups. This would allow those with an elevated concentration of CEA to be treated even before cancer cells spread in the body.

"Right now cancer is detected closer to end stage," Ameen noted. "We want to detect it as early as possible. Our device is providing us with that opportunity."

While this study demonstrated detection in a small human serum sample, the method could be used for the detection of other diseases down the road.

"In the future, if they are made very cost-effective and portable," Hackett said, "it would be great to see people be able to take more control over their health and monitor something like this on their own."

Abid Ameen | EurekAlert!

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First diode for magnetic fields

Innsbruck quantum physicists have constructed a diode for magnetic fields and then tested it in the laboratory. The device, developed by the research groups led by the theorist Oriol Romero-Isart and the experimental physicist Gerhard Kirchmair, could open up a number of new applications.

Electric diodes are essential electronic components that conduct electricity in one direction but prevent conduction in the opposite one. They are found at the...

Im Focus: Nonstop Tranport of Cargo in Nanomachines

Max Planck researchers revel the nano-structure of molecular trains and the reason for smooth transport in cellular antennas.

Moving around, sensing the extracellular environment, and signaling to other cells are important for a cell to function properly. Responsible for those tasks...

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Optical Coherence Tomography: German-Japanese Research Alliance hosted Medical Imaging Conference

19.11.2018 | Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

 
Latest News

Removing toxic mercury from contaminated water

21.11.2018 | Life Sciences

New China and US studies back use of pulse oximeters for assessing blood pressure

21.11.2018 | Medical Engineering

Exoplanet stepping stones

21.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>